Gratus Capital LLC Amgen Inc Transaction History

Gratus Capital LLC

  • $2.39 Billion
  • Q2 2024

A detailed history of Gratus Capital LLC transactions in Amgen Inc stock. As of the latest transaction made, Gratus Capital LLC holds 47,852 shares of AMGN stock, worth $12.6 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares
47,852
Previous 46,570 2.75%
Holding current value
$12.6 Million
Previous $13.2 Million 12.92%
% of portfolio
0.62%
Previous 0.63%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024
BUY
$262.75 - $319.31 $336,845 - $409,355
1,282 Added 2.75%
47,852 $15 Million
Q1 2024

May 13, 2024
BUY
$268.87 - $324.56 $275,860 - $332,998
1,026 Added 2.25%
46,570 $13.2 Million
Q4 2023

Feb 07, 2024
SELL
$255.7 - $288.46 $199,701 - $225,287
-781 Reduced 1.69%
45,544 $13.1 Million
Q3 2023

Oct 26, 2023
BUY
$218.65 - $271.46 $66,250 - $82,252
303 Added 0.66%
46,325 $12.5 Million
Q2 2023

Aug 02, 2023
BUY
$214.27 - $253.37 $235,482 - $278,453
1,099 Added 2.45%
46,022 $10.2 Million
Q1 2023

Apr 19, 2023
SELL
$225.79 - $275.2 $248,369 - $302,720
-1,100 Reduced 2.39%
44,923 $10.9 Million
Q4 2022

Jan 27, 2023
BUY
$229.03 - $291.01 $9.87 Million - $12.5 Million
43,101 Added 1475.05%
46,023 $0
Q3 2022

Nov 03, 2022
SELL
$224.46 - $253.15 $53,421 - $60,249
-238 Reduced 7.53%
2,922 $659,000
Q2 2022

Jul 29, 2022
BUY
$230.71 - $256.74 $155,267 - $172,786
673 Added 27.06%
3,160 $769,000
Q1 2022

Apr 29, 2022
SELL
$219.27 - $242.57 $19,515 - $21,588
-89 Reduced 3.45%
2,487 $602,000
Q4 2021

Jan 31, 2022
BUY
$198.88 - $227.6 $3,778 - $4,324
19 Added 0.74%
2,576 $580,000
Q3 2021

Nov 05, 2021
SELL
$212.27 - $248.7 $112,715 - $132,059
-531 Reduced 17.2%
2,557 $544,000
Q2 2021

Aug 10, 2021
SELL
$233.58 - $259.14 $470,897 - $522,426
-2,016 Reduced 39.5%
3,088 $753,000
Q4 2020

Feb 03, 2021
BUY
$216.38 - $257.67 $22,936 - $27,313
106 Added 2.12%
5,104 $1.17 Million
Q3 2020

Oct 30, 2020
SELL
$234.65 - $260.95 $63,824 - $70,978
-272 Reduced 5.16%
4,998 $1.27 Million
Q2 2020

Aug 11, 2020
SELL
$197.81 - $242.74 $66,068 - $81,075
-334 Reduced 5.96%
5,270 $1.24 Million
Q1 2020

May 01, 2020
SELL
$182.24 - $241.7 $25,149 - $33,354
-138 Reduced 2.4%
5,604 $1.14 Million
Q4 2019

Feb 07, 2020
SELL
$189.21 - $243.2 $54,870 - $70,528
-290 Reduced 4.81%
5,742 $1.38 Million
Q3 2019

Oct 30, 2019
SELL
$174.11 - $208.62 $71,036 - $85,116
-408 Reduced 6.34%
6,032 $1.17 Million
Q2 2019

Aug 07, 2019
SELL
$166.7 - $195.41 $16,336 - $19,150
-98 Reduced 1.5%
6,440 $1.19 Million
Q1 2019

May 14, 2019
SELL
$180.87 - $203.88 $49,558 - $55,863
-274 Reduced 4.02%
6,538 $1.24 Million
Q4 2018

Feb 14, 2019
SELL
$178.4 - $208.25 $53.7 Million - $62.6 Million
-300,751 Reduced 97.79%
6,812 $1.33 Million
Q4 2018

Feb 13, 2019
BUY
$178.4 - $208.25 $53.7 Million - $62.7 Million
301,103 Added 4661.04%
307,563 $1.78 Million
Q3 2018

Nov 09, 2018
SELL
$185.29 - $208.89 $35,575 - $40,106
-192 Reduced 2.89%
6,460 $1.34 Million
Q2 2018

Aug 13, 2018
SELL
$166.05 - $186.51 $141,640 - $159,093
-853 Reduced 11.37%
6,652 $1.23 Million
Q1 2018

May 10, 2018
BUY
$169.43 - $198.0 $37,613 - $43,956
222 Added 3.05%
7,505 $1.28 Million
Q4 2017

Feb 07, 2018
SELL
$168.79 - $188.59 $42,366 - $47,336
-251 Reduced 3.33%
7,283 $1.27 Million
Q3 2017

Nov 09, 2017
SELL
$167.29 - $191.0 $155,746 - $177,821
-931 Reduced 11.0%
7,534 $1.41 Million
Q2 2017

Aug 08, 2017
BUY
N/A
8,465
8,465 $1.46 Million

Others Institutions Holding AMGN

# of Institutions
3,125
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Gratus Capital LLC Portfolio

Follow Gratus Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gratus Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gratus Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email